FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Caplin Point Laboratories LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524742 NSE Symbol: CAPLIPOINT P/E (TTM) :37.7
ISIN Demat:INE475E01026 Div & Yield %:0.34 EPS (TTM) :35.31
Book Value (RS) :166.6933427 Market Cap (Rs Cr.):10108.61 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Dec 2023)		 Quarter Ended
(Dec 2022)		 Quarter Ended
(% Var)
Sales 132.83 130.60 1.71
Other Income 17.90 29.36 -39.03
PBIDT 81.22 80.87 0.43
Interest 0.03 0.04 -25.00
PBDT 81.19 80.83 0.45
Depreciation 6.76 6.47 4.48
PBT 74.43 74.36 0.09
Tax 19.91 16.85 18.16
Deferred Tax -0.93 -1.66 0.00
PAT 55.45 59.17 -6.29

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)